Trial · NCT01589302
Adverse events158
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
101 to 120 of 158
Download this page as JSON| Type | Event | Organ system | Group | Affected | At risk | Events |
|---|---|---|---|---|---|---|
| serious | Fatigue | General disorders | Treatment (Ibrutinib) | 1 | 152 | 1 |
| serious | Fever | General disorders | Treatment (Ibrutinib) | 4 | 152 | 4 |
| serious | General Disorders and Administration Site Conditions - Other | General disorders | Treatment (Ibrutinib) | 3 | 152 | 3 |
| serious | Non-Cardiac Chest Pain | General disorders | Treatment (Ibrutinib) | 1 | 152 | 1 |
| serious | Sudden Death NOS | General disorders | Treatment (Ibrutinib) | 1 | 152 | 1 |
| serious | Cholecystitis | Hepatobiliary disorders | Treatment (Ibrutinib) | 2 | 152 | 4 |
| serious | Immune System Disorders - Other | Immune system disorders | Treatment (Ibrutinib) | 1 | 152 | 1 |
| serious | Bone Infection | Infections and infestations | Treatment (Ibrutinib) | 3 | 152 | 3 |
| serious | Bronchial Infection | Infections and infestations | Treatment (Ibrutinib) | 4 | 152 | 4 |
| serious | Catheter Related Infection | Infections and infestations | Treatment (Ibrutinib) | 2 | 152 | 2 |
| serious | Enterocolitis Infectious | Infections and infestations | Treatment (Ibrutinib) | 3 | 152 | 3 |
| serious | Infections and Infestations-other | Infections and infestations | Treatment (Ibrutinib) | 13 | 152 | 16 |
| serious | Lung Infection | Infections and infestations | Treatment (Ibrutinib) | 32 | 152 | 53 |
| serious | Otitis Media | Infections and infestations | Treatment (Ibrutinib) | 2 | 152 | 2 |
| serious | Pharyngitis | Infections and infestations | Treatment (Ibrutinib) | 1 | 152 | 1 |
| serious | Sepsis | Infections and infestations | Treatment (Ibrutinib) | 6 | 152 | 7 |
| serious | Sinusitis | Infections and infestations | Treatment (Ibrutinib) | 1 | 152 | 1 |
| serious | Skin Infection | Infections and infestations | Treatment (Ibrutinib) | 4 | 152 | 4 |
| serious | Soft Tissue Infection | Infections and infestations | Treatment (Ibrutinib) | 2 | 152 | 3 |
| serious | Upper Respiratory Infection | Infections and infestations | Treatment (Ibrutinib) | 5 | 152 | 5 |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT01589302/events?page=6